Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group studyMartine Van Glabbeke, Jaap Verweij, Paolo G Casali, et al.Molecular Cancer Therapeutics|June 11, 2009
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumorsRichard D Baird, Jos Kitzen, Paul A Clarke, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumorsDebashis Sarker, Rhoda Molife, T R Jeffrey Evans, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignanciesChooi P Lee, Maja J A de Jonge, Anne E O'Donnell, et al.The Oncologist|March 22, 2015
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumorsChooi Peng Lee, N Jane Taylor, Gerhardt Attard, et al.Lancet (London, England)|October 19, 2006
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trialGeorge D Demetri, Allan T van Oosterom, Christopher R Garrett, et al.The Lancet. Oncology|June 26, 2007
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective studyFederica Grosso, Robin L Jones, George D Demetri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2017
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose LevelsPaolo G Casali, John Zalcberg, Axel Le Cesne, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue SarcomaChristopher W Ryan, Ofer Merimsky, Mark Agulnik, et al.JAMA Surgery|April 3, 2020
Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant ImatinibAlessandro Gronchi, Sylvie Bonvalot, Andres Poveda Velasco, et al.Pageof 5